Hannover Re FY25 Profit, Reinsurance Revenue Climb; Confirms FY26 Profit View

Hannover Re reported preliminary FY2025 results with Group net income rising to €2.64 billion from €2.33 billion and operating profit (EBIT) increasing to €3.5 billion from €3.3 billion; reinsurance revenue was €26.8 billion versus €26.4 billion a year earlier. Property & casualty reinsurance EBIT improved to €2.6 billion, treaty renewals boosted traditional P&C premium income by 3.3% as of Jan. 1, 2026, and management maintained FY2026 net income guidance of at least €2.7 billion (a 12.5% rise vs the prior-year original forecast).

Analysis

MARKET STRUCTURE: Hannover Re's preliminary FY25 shows resilience — Group net income €2.64bn and guidance ≥€2.7bn for FY26, with treaty price increases of ~3.3% at Jan 1, 2026 and reinsurance revenue €26.8bn. Winners: reinsurers with strong underwriting discipline (Hannover Re, Munich Re) and brokers (AON, MMC) capturing higher commission pools; losers: primary P&C insurers with thin pricing power or high catastrophe exposure as reinsurance costs climb. Cross-asset: stronger reinsurer earnings should mildly tighten credit spreads in EURIG credit and support EUR vs USD; catastrophe bond spreads may compress if capacity improves, while equity vols for reinsurers should drift lower absent major cat events.

RISK ASSESSMENT: Tail risks include a severe catastrophe season (>€50–100bn global insured loss), Solvency II capital changes, or sharp investment yield declines that could erode the ~€0.06–0.1bn sensitivity per 100bp move in yields (firm-specific sensitivity may vary). Immediate risk window: audited results on Mar 12 and Q1 cat activity; short-term (3–6 months) sensitivity to retrocession pricing and US hurricane outcomes; long-term depends on frequency of large nat-cat events and sustained rate adequacy. Hidden dependency: meaningful portion of revenue denominated in USD — EUR/USD moves >2% quarter-on-quarter can swing reported earnings materially.

TRADE IMPLICATIONS: Direct play: favor selective long exposure to Hannover Re (HVRRY/HVRRF) and select peers with conservative reserving; use 3–6 month call spreads to capture upside while capping cost. Pair trade: long HVRRY vs short Swiss Re (SREN.SW) to express relative underwriting discipline; target spread outperformance of 5–10% over 3–6 months. Reallocate 1–3% from primary P&C names (e.g., CB, TRV) into reinsurers; be ready to trim if stock rallies >10% or sector-wide cat losses exceed €20bn.

CONTRARIAN ANGLES: Consensus may read guidance as unequivocally bullish while underestimating cat tail risk and modest 3.3% rate increases — pricing is still moderate versus prior hard markets, so upside could be limited. Historical parallels (post-2017 hardening then softening) warn that new capacity can emerge within 12–24 months, compressing margins; if investment yields fall or reserve releases reverse, earnings beats could prove short-lived. A prudent entry waits for audited confirmation on Mar 12, then scales on dips of 3–7%.

Key Decisions for Investors

• Establish a 2–3% long position in Hannover Re via HVRRY (OTC) or HVRRF (ADR) ahead of audited results on Mar 12; add up to another 1% on any post-report pullback of 3–7%, and take partial profits if the share price rallies >10% or if guidance is trimmed below €2.7bn.
• Initiate a 2% pair trade: long HVRRY and short Swiss Re (SREN.SW) equal notional; target relative outperformance of 5–10% within 3–6 months, stop-loss if the long leg down >10% or spread narrows by 50%.
• Implement a 3–6 month call spread on HVRRY (buy ATM call, sell +10% strike) to express upside with defined cost; size to equal no more than 1% portfolio risk and close if implied vol rises >30% or sector cat losses exceed €20bn in a quarter.
• Reduce exposure by 1–2% to selected primary P&C insurers (e.g., Chubb CB, Travelers TRV) over the next 4 weeks and reallocate into reinsurers, reversing if evidence of sustained reinsurance price erosion appears over two consecutive quarter renewals.